id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-5925-0039,FDA,FDA-2017-N-5925,21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,Notice,Request for Comments,2025-04-09T04:00:00Z,2025,4,2025-04-09T04:00:00Z,,2025-04-09T14:23:12Z,2025-06048,1,0,0900006486a7e997
FDA-2017-N-5925-0034,FDA,FDA-2017-N-5925,21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,Notice,Request for Comments,2024-04-09T04:00:00Z,2024,4,2024-04-09T04:00:00Z,,2025-01-11T02:00:49Z,2024-07495,1,0,09000064864c2b3b
FDA-2017-N-5925-0031,FDA,FDA-2017-N-5925,"21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page, 2021 and 2022 Updates; Request for Comments",Notice,Request for Comments,2023-05-18T04:00:00Z,2023,5,2023-05-18T04:00:00Z,,2024-11-07T01:34:34Z,2023-10603,1,0,0900006485a1c692
FDA-2017-N-5925-0027,FDA,FDA-2017-N-5925,21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,Notice,Request for Comments,2022-01-28T05:00:00Z,2022,1,2022-01-28T05:00:00Z,,2022-01-28T14:03:14Z,2022-01693,0,0,0900006484f410b7
FDA-2017-N-5925-0026,FDA,FDA-2017-N-5925,21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,Notice,Request for Comments,2020-10-22T04:00:00Z,2020,10,2020-10-22T04:00:00Z,,2020-10-22T13:03:43Z,2020-23439,0,0,0900006484925e34
FDA-2017-N-5925-0016,FDA,FDA-2017-N-5925,21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,Notice,Announcement,2019-05-03T04:00:00Z,2019,5,2019-05-03T04:00:00Z,,2024-11-12T23:00:29Z,2019-09007,1,0,0900006483c2d8ac
FDA-2017-N-5925-0012,FDA,FDA-2017-N-5925,"Susceptibility Test Interpretive Criteria Recognized and Listed on the
Susceptibility Test Interpretive Web Page; Reopening of a Public Docket;
Request for Comments",Notice,Request for Comments,2018-03-01T05:00:00Z,2018,3,2018-03-01T05:00:00Z,,2025-01-18T02:01:12Z,2018-04175,1,0,0900006482f7a3ab
FDA-2017-N-5925-0011,FDA,FDA-2017-N-5925,21st Century Cures Act: Announcing the Establishment of the Susceptibility Test Interpretive Criteria Website,Notice,Announcement,2017-12-13T05:00:00Z,2017,12,2017-12-13T05:00:00Z,,2017-12-13T17:37:08Z,2017-26790,0,0,0900006482d01f46
FDA-2017-N-5925-0001,FDA,FDA-2017-N-5925,"Standard Development Organizations Whose Susceptibility Test Interpretive Criteria Standards May Be Recognized by the Food and Drug 
Administration; Request for Information",Notice,Requests for Information (RFI),2017-10-30T04:00:00Z,2017,10,2017-10-30T04:00:00Z,2017-11-30T04:59:59Z,2017-11-30T02:01:35Z,2017-23519,0,0,0900006482c21694